These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16751381)

  • 1. Estrogen induces thymic atrophy by eliminating early thymic progenitors and inhibiting proliferation of beta-selected thymocytes.
    Zoller AL; Kersh GJ
    J Immunol; 2006 Jun; 176(12):7371-8. PubMed ID: 16751381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of thymic progenitors in adult mouse bone marrow.
    Perry SS; Pierce LJ; Slayton WB; Spangrude GJ
    J Immunol; 2003 Feb; 170(4):1877-86. PubMed ID: 12574354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
    Xi H; Kersh GJ
    J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes.
    Bunin A; Khwaja FW; Kersh GJ
    J Immunol; 2005 Aug; 175(3):1532-9. PubMed ID: 16034091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
    Kwon H; Jun HS; Khil LY; Yoon JW
    J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
    Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
    J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.
    Coles MC; Raulet DH
    J Immunol; 2000 Mar; 164(5):2412-8. PubMed ID: 10679077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.
    Lacorazza HD; Tucek-Szabo C; Vasović LV; Remus K; Nikolich-Zugich J
    J Immunol; 2001 Mar; 166(5):3184-93. PubMed ID: 11207271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tid1 is required for T cell transition from double-negative 3 to double-positive stages.
    Lo JF; Zhou H; Fearns C; Reisfeld RA; Yang Y; Lee JD
    J Immunol; 2005 May; 174(10):6105-12. PubMed ID: 15879105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
    McKean DJ; Huntoon CJ; Bell MP; Tai X; Sharrow S; Hedin KE; Conley A; Singer A
    J Immunol; 2001 Mar; 166(5):3468-75. PubMed ID: 11207305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.
    Shanker A; Auphan-Anezin N; Chomez P; Giraudo L; Van den Eynde B; Schmitt-Verhulst AM
    J Immunol; 2004 Apr; 172(8):5069-77. PubMed ID: 15067090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in absence of a thymus, the enforced expression of the Notch ligands delta-1 or delta-4 promotes T cell development with specific unique effects.
    de La Coste A; Six E; Fazilleau N; Mascarell L; Legrand N; Mailhé MP; Cumano A; Laâbi Y; Freitas AA
    J Immunol; 2005 Mar; 174(5):2730-7. PubMed ID: 15728481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of thymic involution induced by murine cytomegalovirus infection.
    Price P; Olver SD; Gibbons AE; Teo HK; Shellam GR
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():155-65. PubMed ID: 7688711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of CD8 transgene expression inhibits the transition from DN3 to DP thymocytes.
    Wack A; Coles M; Norton T; Hostert A; Kioussis D
    J Immunol; 2000 Aug; 165(3):1236-42. PubMed ID: 10903721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.